Nicholas A. Saccomano

Director & President and CEO

Director & President and CEO at OnKure Therapeutics, Inc., filing insider transactions on 2026-09-21.

Total Purchases

—

0 transactions

Total Sales

$259

1 transaction

Companies Traded

1 total filings

Active Since

2026-09-21

Last: 2026-09-21

Companies

OnKure Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-21	OKUR	Sale	87	$2.97	$259	11.2K	SEC ↗